×

img Acces sibility Controls

Research Projects Banner

Research Projects

Understanding the mechanism of osteopreia and aberrant bone formation, and discovery of new targets for skeletal medicine (Osteo Target)

Implementing Organization

CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow
Principal Investigator
Dr Naibedya Chattopadhyay
Scientist
|
CSIR-Central Drug Research Institute (CSIR-CDRI), Lucknow

About

Objective: Identification of sclerostin-derived peptides with the ability to inhibit the Wnt­signaling pathway and characterization of their bone-growth inhibiting properties b) To examine in vivo activity of such peptides for investigating their efficacy in an osteoarthritis animal model c) To identify sclerostin-derived peptides as its inhibitors d) To characterize if these sclerostin-inhibitors can induce bone growth/formation in vitro experiments e) To examine if these sclerostin-inhibitors can induce both growth/formation in vivo animal model f) Understanding the mode of action and structural studies on these sclerostin-mimetic and sclerostin-inhibitory peptides g) PK, stability studies and regulatory (IND-enabling) studies of the lead peptides.

Funding Organization
Funding Organization
Council of Scientific and Industrial Research
Quick Information
Area of Research
Life Sciences & Biotechnology
Focus Area
Skeletal medicine
Start Year
2020
End Year
2025
Status
Completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop